Download Agents to Treat Gastric Acidity and Gastroesophageal Reflux (GERD)
Short Description
Download Download Agents to Treat Gastric Acidity and Gastroesophageal Reflux (GERD)...
Description
Agents to Treat Gastric Acidity and Gastroesophageal Reflux Disease (GERD) Presented by Abby Roth
Overview • Introduction – Symptoms • Causes – Peptic Ulcer Disease • H. pylori • NSAIDs – GERD • Treatments
Who is Affected? Gastric acidity and GERD affects people of all ages, races, and gender
Symptoms • Heartburn • Regurgitation • Acid Indigestion • Nausea
Symptoms Continued • Hoarseness • Sore Throat • Chest Pain • Bad Breath • Dry Cough • Asthma*
Symptoms in Children • Vomiting • Coughing • Breathing Problems
Acid-Peptic Disorders • Peptic Ulcer Disease –Occurs when there is an imbalance between the mucosal defense factors and the acid and pepsin.
Helicobacter pylori Infection • Causes 80% of peptic ulcers • Survives the acid environment by attaching to the sugar molecules that line the stomach wall • Uses the mucus layer as protection
H. pylori • Produce large amounts of urease Urease H20
Urea
3 NH3 + CO2
H. pylori • Secret proteins and toxins that interact with the stomach’s epithelial cells • Leads to inflammation and damage
NSAIDs • Aspirin, Ibuprofen, Naproxen • Can have an affect at very low doses • Suppresses cylooxygenase-1 • Decrease production of prostaglandins
What is GERD? • Condition where the stomach acid/content is pushed back or “refluxed” into the esophagus • Affects 10 million Americans • Approximately 7% have daily symptoms • Link
GERD vs. NERD • Patients suffering symptoms are placed in two groups –Non-erosive reflux disease, or NERD –Erosive esophagitis • Erosive esophagitis is characterized by swelling and Inflammation –Barrett’s Esophagus –Precursor to Esophageal Cancer
Causes of GERD • Abnormalities with the Lower Esophageal Sphincter, or LES • Stomach Abnormalities –Hiatal hernia –Link
Causes • Medications –NSAIDs –Calcium Channel Blockers (high blood pressure, angina)
Medications –Anticholinergics (urinary tract disorders) –Beta Adrenergic Agonists (asthma) –Dopamine (Parkinson’s disease)
Causes • Food and Drinks – Carbonated beverages – Chocolate – Alcohol – Citrus Fruits – Coffee or Tea – Fatty foods – Containing tomatoes – Mint – Spicy Food
Causes • Smoking – Damages mucus membranes – Impairs muscle reflexes in the throat – Increases acid secretion – Reduces LES function and salivation
Causes • Obesity • Laying down after a large meal • Eating close to bed time • Exercise
Release of Gastric Acid
Release of Gastric acid • Histamine stimulates acid release by interacting with the histamine receptor, H2 • Acetylcholine activates the cholinergic receptors • Gastrin is released when food is present in the stomach
Treatments • • • • • • •
Antacids Alginates Sucralfate Proton Pump Inhibitors Histamine H2-Recptor Antagonists Prokinetics New Treatments
Antacids • Quick but short term • Buffer gastric acid, increasing the pH • Neutralize acid by the following reaction Al(OH)3 + 3 HCl
AlCl3 + 3 H2O
Antacids –Maalox • Al(OH)3 (aluminum hydroxide), Mg(OH)2 (magnesium hydroxide)
Antacids • Tums • CaCO3 (calcium carbonate)
Antacids –Pepto-Bismol • C7H5BiO4 (bismuth subsalicylate)
Antacids –Alka-Seltzer • NaHCO3 (sodium bicarbonate)
Alginates • Alginates –Usually combined with an antacid –Forms protective barrier on top of gastric contents –Gaviscon • Sodium Alginate, Sodium Bicarbonate, and Calcium Carbonate –Link
Alginates • Polysaccharide found in the cell walls of brown algae • Sodium alginate is the sodium salt of alginic acid
Alginic Acid
Sucralfate • Reacts with stomach acid to from a cross linked viscous polymer that acts as an acid buffer • Can bind to proteins on the surface of an ulcer to prevent further acid damage • Has been shown to aid in healing by promoting epidermal growth factors and prostaglandins
Sucralfate (Carafate)
Proton Pump Inhibitors • Proton pump inhibitors (PPIs) – Inhibits the gastric acid pump, H+/K+ ATPase – Are prodrugs
PPIs • Diffuse into the parietal cells of the stomach and accumulates • Activated by proton-catalyzed formation of sulfenic acid • This prevents the drug from diffusing out • Activated form then irreversibly binds at the sulfhydryl groups of the cysteins of the H+/K+ ATPase • Link
Cysteine
PPIs
Rabeprazol (Acipex)
PPIs
Lansoprazole (Prevacid)
PPIs
Esomeprazole (Nexium)
PPIs
Omeprazole (Prilosec) Omeprazole/sodium bicarbonate (Zegerid)
PPIs
Pantoprazole (Protonix)
Treatments • Histamine H2-recptor antagonists (H2RAs) • The hormone, histamine stimulates the release of acid by interacting with the histamine receptor, or H2 receptor. • Inhibit acid secretion by competitively and reversibly blocking parietal cell H2receptors • Less potent then PPI’s
Agonist vs. Antagonist • An agonist is a drug that produces the same response at a receptor as the natural messenger • An antagonist is a drug which binds to a receptor without activating it, prevent an agonist or natural messenger from binding
Histamine
H2RAs
Cimetidine (Tagamet)
H2RAs
Nizatidine (Axid)
Other H2RAs
Famotidine (Pepcid)
Ranitidine HCl (Zantac)
Treatments • Prokinetics –Increase LES function –Release stomach contents by •Activating serotonin receptors •Acting on dopaminergic receptors
Prokinetics
Metoclopramide (Reglan, Degan)
Prokinetics
Domperidone (Motilium, Costi)
Prokinetics
Cisapride (Prepulsid, Propulsid)
Prokinetics • Rarely used because of severe side effects – Fatigue –Tremors –Parkinsonism –Tardive Dyskinesia –Severe cardiac events
New Treatments • Cholecystokinin2 receptor antagonists (CCK2) • Potassium competitive acid blockers (P-CABs)
Treatments • Cholecystokinin2 receptor antagonists (CCK2) –Block the CCK2 receptors inhibiting acid secretion –Still in clinical trials –Best use in combination with PPI’s
CCK2
Itriglumide
CCK2
Z-360
Treatments • Potassium competitive acid blockers (P-CABs) – Target H+/K+ ATPase – Ionically binds to the proton pump – Specific for the K+ binding region and prevents acid secretion – Binds reversibly – Still in clinical trials
P-CABs
Revaprazan
P-CABs
Soraprazan
Treatment for H. pylori • Amoxicillin + clarithromycin + proton pump inhibitor • Metronidazole + clarithromycin + proton pump inhibitor • Bismuth subsalicylate + metronidazole + tetracycline + proton pump inhibitor
Assigned Reading • Vesper, J.B. et all, Gastroesophageal Reflux Diesease, Is there More to the Story?, ChemMedChem (2008), 3, 552-559.
Homework Questions • What is an antagonist and how do the H2RAs (histamine receptor antagonists) act as one? • Explain the precise biological mechanism whereby prokinetics achieve their effect, including the receptors they act upon. Are they agonists or antagonists? Of which chemical messenger? • What is a prodrug? What causes the PPI’s to become an active drug? • Bacteria in the upper GI tract may play a role in GERD. Explain.
References • Bak, Young-Tae. Management Strategies for Gastroesophageal Reflux Disease. Journal of Gastroenterology and Hepatology (2004), 19, S49-S53. • Horn, J. Understanding the Pharmacodynamic and Pharmacokinetic Differences between proton pump inhibitors- focus on pKa and metabolism. AP&T (2006), 2, 340-350. • Pettit, M. Treatment of Gastroesophageal Reflux Disease. Pharm World Sci (2005) 27, 432-435. • Vakil, N., New Pharmacological Agents for the Treatment of Gastroesophageal Reflux Disease. AP&T (2006), 19, 1041-1049. • Vesper, J.B. et all, Gastroesophageal Reflux Diesease, Is there More to the Story?, ChemMedChem (2008), 3, 552-559. • Goodman and Gilman pg 967-980. • Patrick pg 643-671.
View more...
Comments